A comparative analysis of interface quality of mobile access to the services of selected banks

This paper is focused on comparison of interface quality of mobile access to the services of selected banks. Main factors, which wereused in the comprising process are: safety, availability on the mobile platforms, time and simplicity of task performing, intelligibility, design, comfort, number of functions. Research was made using 4 methods: surveys, corridor tests, expert tests and eyetracking. As a result T-Mobile Banking Services won in three categories: intelligibility, design and simplicity while mBank is better in responsiveness, availability and has more functions to offe

Balonowa angioplastyka tętnic płucnych — innowacyjna metoda przezskórnego leczenia chorych na przewlekłe zakrzepowo- -zatorowe nadciśnienie płucne

Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by the presence of chronic thrombi in the pulmonary arteries and pulmonary hypertension confirmed on the right heart catheterization. In the treatment of CTEPH it is necessary to use the indefinite anticoagulant therapy — mainly as a form of prevention against further episodes of pulmonary embolism. Main goal in treatment of CTEPH is to restore patency of the pulmonary arteries and reduction of pulmonary vascular resistance, using pulmonary endarterectomy, pharmacotherapy with pulmonary vasodilators (sildenafil, riociguat) or interventional approach with balloon pulmonary angioplasty (BPA). Qualification for the appropriate method of treatment is carried out on the CTEPH-TEAM meeting. Current European Society of Cardiology Guidelines recommend BPA in inoperable patients with CTEPH, which in practice means patients with distal location of clots in pulmonary vascular tree and patients at high risk of surgery because of age and coexisting diseases. A separate group of candidates for BPA are patients with a history of pulmonary endarteractomy, in whom persistent pulmonary hypertension is present. The first BPA was carried out in Poland in 2013, and is now performed in 6 centres with total number of procedures exceeding 300.Przewlekłe nadciśnienie płucne zakrzepowo-zatorowe (CTEPH) charakteryzuje się obecnością przewlekłych skrzeplin w tętnicach płucnych oraz wymaga potwierdzenia nadciśnienia płucnego w cewnikowaniu prawego serca. W leczeniu CTEPH konieczne jest stosowanie bezterminowego leczenia przeciwzakrzepowego — głównie jako formy prewencji przed kolejnymi epizodami zatorowości płucnej. Leczeniem przyczynowym CTEPH jest przywrócenie drożności tętnic płucnych i redukcja naczyniowego oporu płucnego, za pomocą kardiochirurgicznej endarterektomii płucnej, leczenia specyficznymi wazodylatatorami płucnymi (sildenafil, riociguat) lub terapii interwencyjnej balonową angioplastyką płucną (BPA, balloon pulmonary angioplasty). Kwalifikacja do odpowiedniej metody leczenia odbywa się na posiedzneiu tak zwanego CTEPH-TEAM. Wytyczne European Society of Cardiology (ESC) z 2015 roku rekomendują wykonanie BPA u pacjentów nieoperacyjnych, co w praktyce oznacza chorych z dystalną lokalizacją skrzeplin w naczyniowym łożysku płucnym oraz chorych z wysokim ryzykiem operacji z powodu wieku i chorób współistniejących. Oddzielną grupę stanowią chorzy po przebytej endarterektomii płucnej, u których doszło do nawrotu zatorowości płucnej lub potwierdzono przetrwałe CTEPH. Pierwszy zabieg BPA wykonano w Polsce w 2013 roku, a obecnie liczba procedur wykonanych w sześciuośrodkach przekracza 300

In-hospital diagnostic strategies for acute pulmonary embolism — results of a single-center study based on the experience of a multi-profile clinical hospital

Introduction: Acute pulmonary embolism (APE) is the most severe clinical presentation of venous thromboembolism(VTE) and inappropriate diagnostic strategies of APE lead to death or chronic thromboembolicpulmonary hypertension. Material and methods: In prospective manner we followed patients admitted to a tertiary clinical centerwith APE proven with CT scan within the period of 24 months. We assessed diagnostic strategies of APE indifferent clinical departments of Polish multi-profile hospital and their association with prognosis. Results: A total number of 178 patients with APE were enrolled in the study, of which 56 patients were diagnosedwith APE in the emergency department (ED), 42 in cardiology departments, and 80 in other departments. Nosignificant differences in diagnostic strategies between departments were found. Adherence to ESC guidelineswas 56.1% and it was similar in compared departments (p = 0.648). The in-hospital mortality rate was 6.7%.In the 6 month follow-up period 18.1% of the studied died. Coronary artery disease (p = 0.002), cancer(p = 0.032), serious medical condition (p = 0.047), altered mental status (p = 0.032), CRP(p = 0.006), and hemoglobin (p = 0.023) were identified as predictors of clinical deterioration. Risk factorsfor in-hospital and 6-month mortality were congestive heart failure, serious medical condition, and systolicblood pressure (p < 0.05). Immobility over 3 days and cancer were also identified as predictors of death within6 months (p < 0.001). There was no association between the type of the department, clinical deterioration,in-hospital, and 6-month mortality. Conclusion: There is no difference in APE management and prognosis in different profile departments